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CC BY-NC-ND license (http://creativeBackground: Necrotizing enterocolitis (NEC) in neonates is devastating, and risk-factor identi-
fication is crucial. This study aimed to evaluate risk factors for NEC in different gestational age
(GA) groups.
Methods: Risk factors associated with NEC were investigated using a retrospective case-control
design. Patients with Bell’s Stage NEC  II were divided into three groups based on GA: I, <34
weeks; II, 34 weeks but <37 weeks; III, 37 weeks. Each case was paired with two GA- and
weight-matched controls. Data were collected from medical records, and univariate and con-
ditional logistic regression analyses employed.
Results: A total of 238 cases and 476 controls were enrolled. Variation in the months when NEC
was diagnosed was noted, with a peak in January and a trough in August. Intrahepatic chole-
stasis of pregnancy and transfusion with packed red blood cells were significantly associated
with NEC in preterm infants. Meconium aspiration syndrome was an independent risk factor
for a greater chance of NEC development in full-term infants. Postnatal asphyxia and sepsis
were associated with an increased risk of NEC in all groups. Probiotic use was associated with
a reduced risk of NEC. Patients aged >34 weeks with congenital heart disease were more likely
than controls to have NEC.om (Q. Lu).
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Pediatrics and Neonatology (2016), hConclusion: Intrahepatic cholestasis of pregnancy and meconium aspiration syndrome may be
new risk factors for NEC.
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open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Necrotizing enterocolitis (NEC) is a common and devas-
tating condition in neonates.1 In the USA, the incidence of
NEC is 0.7e1 per 1000 live births, with a significantly higher
incidence among very low-birth-weight infants (5e10%).2,3
In general, it is thought that 90% of all NEC cases are pre-
mature, but full-term infants account for approximately
7e25% of NEC cases.3e5 In some cases, the incidence of NEC
has increased because of ever-improving survival in the
smallest infants.6 A severe complication, neuro-
developmental delay, can develop in 25% of patients
recovering from NEC resulting in catastrophic long-term
consequences. NEC is associated with substantial medical
burdens to both families and society.7,8 The pathogenesis of
NEC is incompletely understood, and epidemiological ob-
servations strongly suggest a multifactorial cause.9,10
As a consequence of the fulminant nature of NEC, it is
unlikely that new diagnostic and treatment strategies will
provide major breakthroughs in reducing the associated
mortality and morbidity. The identification of possible risk
factors is more likely to provide better results.11,12
Numerous studies have been undertaken to investigate
the risk factors for NEC. Commonly observed risk factors
are prematurity, low birth-weight, enteral feeding, blood
transfusion, and sepsis. Breast milk and probiotics have
been demonstrated to be protective factors.13e17 However,
whether neonates with other risk factors might also have a
chance of contacting NEC is not clear.
Shemer et al18 reported previously that intrahepatic
cholestasis of pregnancy (ICP) could increase the risk of
preterm delivery and other adverse fetal outcomes. Nissen
et al19 reported that a family history of allergic disease may
be associated with sensitization of the intestinal tract in
neonates and children. Cayabyab et al20 reported that
meconium aspiration syndrome (MAS) may lead to fetal
hypoxia via lung dysfunction and systemic inflammatory
response. The above three clinical situations may be also
associated with an increased risk of NEC. However, well-
powered studies that can elucidate the association be-
tween the above conditions with NEC are lacking.
We aimed to evaluate the risk factors mentioned above
and reconfirmed other, previously demonstrated risk fac-
tors. We also explored whether their effects differ by
gestational age (GA) in a retrospective case-control study.2. Materials and methods2.1. Design and setting of our study
We undertook a retrospective case-control study to inves-
tigate a range of factors on the risk of NEC in different GAQ, et al., Risk Factors for Necrotiz
ttp://dx.doi.org/10.1016/j.pedngroups. The Chongqing Children’s Hospital is a tertiary-care
teaching hospital in the city of Chongqing, China. Our
neonatal diagnostic center serves >6000 neonates every
year.
Infants with NEC were identified by the International
Classification of Diseases (10th revision) codes. The
Chongqing Children’s Hospital used the ICD-10 system to
replace ICD-9 from January 1, 2010. Clinical and de-
mographic information of each patient was recorded in the
electronic medical record system (MRS) at Chongqing Chil-
dren’s Hospital, and was anonymized before analyses. The
study protocol was approved by the Institutional Review
Board of Chongqing Children’s Hospital.2.2. Population selection
Data collection was conducted through a review of the
patients’ medical records. Patients were identified if they
were classified in the database as having proven NEC (Bell
Stage  II) between March 1, 2010 and March 1, 2015.21,22
Two controls were selected from the database for each
patient and matched for birthdate (difference of <2
months), estimated GA (<1 week apart), and birth-weight
(difference of <100 g).23 Control patients were those
admitted to the same institution for medical reasons other
than NEC before hospital discharge. We stratified infants by
GA into three groups: I, <34 weeks; II, 34 weeks but <37
weeks; III, 37 weeks. Exclusion criteria were any immu-
nodeficiency disease, inherited metabolic disorder, major
gastrointestinal malformations, as well as patients for
whom eligible controls could not be found or for whom
relevant information was insufficient, and those who had
undergone abdominal surgery before enrollment. Medical
records for each case and control were reviewed indepen-
dently by two investigators who were unaware of the study
aims. Disagreements were resolved by consensus between
the two investigators.2.3. Study protocol and data collection
Information on risk factors was obtained from the elec-
tronic MRS of Chongqing Children’s Hospital. Data was
collected until the end of admission for both NEC and non-
NEC groups. Key risk factors were ICP, family history of
allergy, MAS, congenital heart disease (CHD),24,25 postnatal
asphyxia,26 oxygen inhalation (number of days), sepsis, and
transfusion of packed red blood cells (PRBCs). Other char-
acteristics of patients were birthdate, GA, birth-weight,
sex, prenatal/maternal data, mode of delivery, and place
of birth. We also reported exposure to breast milk and
probiotics to ascertain if they may be associated with a
reduced risk of NEC.ing Enterocolitis in Neonates: A Retrospective Case-Control Study,
eo.2016.04.002
Figure 2 Seasonal variation in the months when babies with
NEC are born. NEC Z necrotizing enterocolitis.
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Descriptive assessments of patients were conducted to
examine the variables of interest. Data are the
mean  standard deviation for continuous variables, and
absolute frequencies or percentages for categorical vari-
ables. McNemar’s test and Fisher’s exact test were used for
categorical variables. For continuous variables, groups
were evaluated using the Student t-test and ManneWhitney
U test.
Conditional logistic regression analyses were performed
to determine the possible risk factors for NEC after inclu-
sion in the model of significant variables identified in uni-
variate analyses. Odds ratios were estimated with
confidence intervals at 95%. A p value < 0.05 was consid-
ered significant. All analyses were carried out using SPSS
v19.0 (IBM, Armonk, NY, USA).
3. Results
We identified 238 cases (Grade-II NEC Z 190; Grade-III
NEC Z 48) and 476 controls. Figure 1 illustrates the se-
lection process for these patients.
Figure 2 shows the seasonal variation in the months
when babies with NEC were born, with a peak in January
and a trough in August, which persisted after subgroup
analyses for GA groups.
Table 1 shows the demographic characteristics and re-
sults with risk factors in univariate analyses among
different groups. Table 2 presents the results of conditional
logistic regression analyses including all parameters with
p < 0.05 in univariate analyses.
In the final model, the variables significantly associated
with NEC in Group I were ICP, postnatal asphyxia, sepsis,
and transfusion of PRBCs. Probiotics were associated with aFigure 1 Identification and inclusion of patients in our stud
Please cite this article in press as: Lu Q, et al., Risk Factors for Necrotiz
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednreduced risk of NEC. When compared with Group I, Group II
showed similar results after conditional logistic regression
analyses: ICP, postnatal asphyxia, sepsis, transfusion of
PRBCs and probiotics. Moreover, patients aged 34e37
weeks were more likely than matched controls to have
CHD. In Group III, postnatal asphyxia, MAS, sepsis, and CHD
were independent risk factors for a greater chance of
developing NEC compared with controls.4. Discussion
In this case-control study, seasonal variation in the preva-
lence of NEC was observed in a population in southwest
China. Specific conditions were associated with an
increased risk of NEC: ICP, postnatal asphyxia, MAS, sepsis,
CHD, probiotic use, and transfusion of PRBCs. Relative ef-
fects of many of these risk factors differed in different GAy. GA Z gestational age; NEC Z necrotizing enterocolitis.
ing Enterocolitis in Neonates: A Retrospective Case-Control Study,
eo.2016.04.002
Table 1 Demographic characteristics and clinical variables of interest of cases and controls.
Group I (GA < 34 wks) Group II (34 wks  GA < 37 wks) Group III (GA  37 wks)
Cases
(n Z 66)
Controls
(n Z 132)
p Cases
(n Z 129)
Controls
(n Z 258)
p Cases
(n Z 43)
Controls
(n Z 86)
p
Demographic characteristics
Gestational age (wk) 29.8  1.6 30.7  1.5 0.142 34.8  0.7 35.6  1.2 0.224 38.9  1.2 39.4  2.1 0.186
Birth-weight (g) 1595  368 1680  262 0.551 2360  214 2440  198 0.635 2886  323 2940  176 0.467
Maternal age 28.4  2.1 27.3  3.0 0.323 27.8  1.7 27.1  2.4 0.247 28.6  0.8 29.1  1.6 0.276
Gender
Male 38 (57.6) 75 (56.8) 0.381 76 (58.9) 142 (55.0) 0.292 26 (60.5) 50 (58.1) 0.306
Female 28 (42.4) 57 (43.2) 0.438 53 (41.1) 116 (45.0) 0.203 17 (39.5) 36 (41.9) 0.319
Mode of delivery
Vaginal 26 (39.4) 58 (43.9) 0.474 54 (41.9) 106 (41.1) 0.469 19 (44.2) 39 (45.3) 0.397
C-section 40 (60.1) 74 (56.1) 0.476 75 (58.1) 152 (58.9) 0.394 24 (55.8) 47 (54.7) 0.308
Place of birth
Urban 32 (48.5) 68 (51.5) 0.287 58 (45.0) 108 (41.9) 0.201 21 (48.8) 40 (46.5) 0.103
Rural 28 (42.4) 54 (40.9) 0.108 60 (46.5) 115 (44.6) 0.115 17 (39.6) 38 (44.2) 0.108
Unknown 6 (9.1) 10 (7.6) 0.311 11 (8.5) 35 (13.5) 0.295 5 (11.6) 8 (9.3) 0.302
Risk factors
ICP 9 (13.6) 8 (6.6) 0.021 21 (16.3) 18 (6.9) 0.012 3 (6.9) 4 (4.7) 0.209
Asphyxia after birth 30 (45.5) 34 (25.8) 0.011 48 (37.2) 46 (17.8) 0.019 23 (53.5) 21 (24.4) 0.013
Family allergy history 6 (9.1) 9 (6.8) 0.198 11 (8.5) 21 (8.1) 0.204 4 (9.3) 7 (8.1) 0.387
Breast milk 15 (22.7) 28 (21.2) 0.418 32 (24.9) 70 (27.1) 0.209 11 (25.6) 24 (27.9) 0.307
MAS 1 (1.5) 3 (2.2) 0.682 5 (3.8) 6 (2.4) 0.054 5 (11.6) 5 (5.8) 0.015
Sepsis 28 (42.4) 23 (17.4) 0.006 48 (38.1) 41 (15.9) 0.011 11 (25.6) 12 (13.9) 0.021
Oxygen (d) 5.8  1.1 4.6  0.9 0.114 5.5  1.6 5.1  1.3 0.175 4.8  0.7 4.3  1.2 0.248
CHD 13 (19.7) 25 (18.9) 0.431 21 (16.3) 25 (9.7) 0.016 7 (16.3) 5 (5.8) 0.024
Probiotics 4 (6.1) 15 (11.4) 0.012 9 (7.0) 34 (13.2) 0.021 3 (6.9) 7 (8.1) 0.181
Transfusion of PRBC 16 (24.2) 10 (7.5) 0.011 26 (20.1) 18 (7.0) 0.017 2 (4.6) 3 (3.5) 0.013
A p-value < 0.05 was considered to be statistically significant. Values are expressed as mean  SD or n (%).
CHDZ congenital heart disease; ICPZ intrahepatic cholestasis of pregnancy; MASZ meconium aspiration syndrome; PRBCZ packed
red blood cells.
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could be provided to reduce the risk of NEC among these
groups.
Seasonal variation of the months in which babies with
NEC were born was broadly in accordance with that seen
in other studies. Snyder et al27 reported a period of 6
months with peaks in June and December. Ahle et al28
reported a period of 12 months with a peak in
November and a trough in May. In contrast, our data
demonstrated a period of 12 months with a peak in
January and a trough in August. A peak during cold months
may indicate that climatic and environmental factors in-
fluence the occurrence of NEC. Also, the period when NEC
occurs was identical after subgroup analyses for different
GA groups. However, our conclusion might be biased as
calculations were restricted to premature infants in hos-
pital, which may not reveal the true incidence. In fact, a
large and truly population-based research in Chongqing
will soon be initiated by our institution to obtain more
reliable data.
ICP was associated with an increased risk of NEC for
preterm infants, which has been reported only rarely in the
literature. Although the cause of ICP is complex and largely
unclear, several studies have consistently found an associ-
ation between ICP and adverse outcome in fetuses,
including spontaneous preterm birth, asphyxial events, asPlease cite this article in press as: Lu Q, et al., Risk Factors for Necrotiz
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednwell as meconium staining of amniotic fluid, placenta and
membranes,18,29 Costoya et al30 reported that increased
levels of bile acids in serum cause a reduction in size of
intervillous spaces as a result of swelling of trophoblasts
and edema of the villous stroma within the placenta. These
changes could lower oxygenation to the fetus by reducing
maternal blood flow to intervillous spaces and lead to
hypoxia-ischemia events, which is probably related to
relative production of vascular regulators and contributes
substantially to NEC pathogenesis. This hypothesis must be
tested in a prospective study.
MAS is a major cause of respiratory failure and a common
diagnosis in full-term infants. Increased levels of neutro-
phils and proinflammatory cytokines such as interleukin
(IL)-6, IL-8, and tumor necrosis factor-a also have impor-
tant roles in the pathogenesis of MAS.20,31 However, in our
study, a large amount of cytokines produced in the lung
may have induced inflammation and altered the protective
barriers in the intestine via the vascular circulation. The
intestinal tracts of neonates exposed to meconium-stained
amniotic fluid may also lead to an exaggerated immune
response in the intestine, similar to the way that MAS-
associated lung injury influences the environmental condi-
tions of the intestinal tract, thereby increasing the risk of
NEC. In Group III, all the patients with MAS had nonsevere
disease, and only five (50%) become symptomatic, requiringing Enterocolitis in Neonates: A Retrospective Case-Control Study,
eo.2016.04.002
Table 2 Conditional logistic regression analyses of the risk factors associated with NEC.
b Sb p Wald c2 OR 95% CI
Group I ICP 0.741 0.187 0.036 8.327 2.17 (1.69, 5.61)
Asphyxia after birth 0.941 0.036 0.008 2.187 2.51 (1.61, 4.47)
Sepsis 1.461 0.021 0.003 0.285 3.95 (1.92, 6.38)
Probiotics 0.119 0.216 0.036 0.998 0.87 (0.38, 1.17)
Transfusion of PRBC 1.339 0.018 0.012 2.112 3.02 (1.36, 6.02)
Group II ICP 0.764 0.221 0.019 7.379 2.66 (1.59, 6.24)
Asphyxia after birth 0.717 0.028 0.018 1.723 1.47 (1.31, 4.16)
Sepsis 1.378 0.045 0.009 0.339 3.85 (1.72, 7.64)
Probiotics 0.145 0.376 0.025 0.719 0.79 (0.51, 0.93)
CHD 0.712 0.032 0.021 2.891 1.61 (1.01, 4.23)
Transfusion of PRBC 1.468 0.026 0.005 0.894 2.85 (1.42, 6.31)
Group III Asphyxia after birth 0.651 0.017 0.031 2.496 3.15 (1.67, 4.78)
MAS 0.872 0.036 0.014 0.632 1.49 (0.93, 3.82)
Sepsis 1.361 0.019 0.011 0.756 3.41 (1.14, 5.79)
Probiotics 0.223 0.186 0.019 0.667 0.92 (0.41, 1.54)
CHD 0.696 0.028 0.011 1.893 2.54 (1.15, 3.71)
Values are expressed as mean  SD or n (%).
CHD Z congenital heart disease; CI Z confidence interval; ICP Z intrahepatic cholestasis of pregnancy; MAS Z meconium aspiration
syndrome; OR Z odds ratio; PRBC Z packed red blood cells.
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+ MODELoxygen supplementation rather than ventilatory support. In
our study, the regression coefficient was 0.872 for MAS and
0.651 for postnatal asphyxia. Therefore, MAS may be an
independent contributor to the development of NEC. To
clarify this hypothesis, large controlled prospective trials
are needed.
Several studies have suggested that CHD is associated
with an increased risk of NEC among the late-preterm and
full-term infants.25 After adjustment for GA, the associa-
tion was obvious for late-preterm and full-term infants,
again suggesting that CHD adds to the overall risk of NEC in
this population. Studies have suggested that reduced
mesenteric perfusion is the main cause, although other
etiologic factors also contribute to the development of
NEC.32 The finding that the risk for NEC is correlated with
asphyxia also strongly supports the notion that insufficiency
in mesenteric flow is a risk factor for NEC development.26
Our data supports the results of studies which have
described an association between NEC and PRBC trans-
fusions.33 A recent retrospective study reported that 27% of
infants are given PRBC transfusions within 48 hours of the
diagnosis of NEC.34 Anemia of prematurity and hyper-
bilirubinemia are common in preterm infants, and PRBC
transfusion has an important role in therapy.35 We also
included breast milk as a risk factor, but it did not reach
significance in conditional logistic regression analyses. In
our experience, this phenomenon results from the low
proportion of breast feeding in Chinese society.36 In addi-
tion, the association of NEC with sepsis and probiotics was
in accordance with other studies.13,17
Our study had specific strengths. This was the first study
to report the risk factors for NEC in which different GA
groups were included simultaneously. Also, it comprised a
large sample population investigated over 5 years, thereby
providing high statistical power for the detection of new
potential risk factors. Among these risk factors, ICP and
MAS have been rarely reported.Please cite this article in press as: Lu Q, et al., Risk Factors for Necrotiz
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednHowever, our study had limitations because of its
retrospective nature of data collection. First, our study
may have been subject to various sources of bias. In gen-
eral, a multicenter and large-sample study can diminish any
bias in the prevalence of admission, but our study was
based at one center. Second, due to the limited number of
patients graded as  II using the Bell classification, some
mild cases of NEC may have been missed, thereby leading
to underestimation of associations. Finally, the retrospec-
tive nature of our study limited us to information recorded
in the MRS, and some important data may not have been
recorded.5. Conclusion
A range of conditions was found to be associated with an
increased risk of NEC. In this study, ICP and MAS may be new
risk factors for NEC. Attention should be paid to these risk
factors in future medical practices. However, the results of
our study must be interpreted with caution due to the
limitations imposed by the study design. To validate these
findings, a larger sample and multicenter prospective study
are needed. If these factors are validated, appropriate
medical interventions to reduce the devastating impact of
this disease can be implemented.Conflicts of interest
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